Your browser doesn't support javascript.
loading
Potential antivirulence and antibiofilm activities of sub-MIC of oxacillin against MDR S. aureus isolates: an in-vitro and in-vivo study.
Omar, Amira; El-Banna, Tarek E; Sonbol, Fatma I; El-Bouseary, Maisra M.
Afiliación
  • Omar A; Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. amira_omar@pharm.tanta.edu.eg.
  • El-Banna TE; Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
  • Sonbol FI; Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
  • El-Bouseary MM; Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. maysra_mohamed@pharm.tanta.edu.eg.
BMC Microbiol ; 24(1): 295, 2024 Aug 09.
Article en En | MEDLINE | ID: mdl-39123138
ABSTRACT

BACKGROUND:

Multi-drug resistant Staphylococcus aureus is one of the most common causes of nosocomial and community-acquired infections, with high morbidity and mortality. Treatment of such infections is particularly problematic; hence, it is complicated by antibiotic resistance, and there is currently no reliable vaccine. Furthermore, it is well known that S. aureus produces an exceptionally large number of virulence factors that worsen infection. Consequently, the urgent need for anti-virulent agents that inhibit biofilm formation and virulence factors has gained momentum. Therefore, we focused our attention on an already-approved antibiotic and explored whether changing the dosage would still result in the intended anti-virulence effect.

METHODS:

In the present study, we determined the antibiotic resistance patterns and the MICs of oxacillin against 70 MDR S. aureus isolates. We also investigated the effect of sub-MICs of oxacillin (at 1/4 and 1/8 MICs) on biofilm formation using the crystal violet assay, the phenol-sulphuric acid method, and confocal laser scanning microscopy (CLSM). We examined the effect of sub-MICs on virulence factors and bacterial morphology using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and electron microscopy, respectively. Moreover, we studied the effect of sub-MICs of oxacillin (OX) in-vivo using a wound infection model.

RESULTS:

Oxacillin at 1/2 MIC showed a significant decrease in bacterial viability, while 1/4 and 1/8 MICs had negligible effects on treated bacterial isolates. Treatment of MDR isolates with 1/4 or 1/8 MICs of oxacillin significantly reduced biofilm formation (64% and 40%, respectively). The treated MDR S. aureus with sub-MICs of OX exhibited a dramatic reduction in several virulence factors, including protease, hemolysin, coagulase, and toxic shock syndrome toxin-1 (TSST-1) production. The sub-MICs of OX significantly decreased (P < 0.05) the gene expression of biofilm and virulence-associated genes such as agrA, icaA, coa, and tst. Furthermore, oxacillin at sub-MICs dramatically accelerated wound healing, according to the recorded scoring of histological parameters.

CONCLUSION:

The treatment of MDR S. aureus with sub-MICs of oxacillin can help in combating the bacterial resistance and may be considered a promising approach to attenuating the severity of S. aureus infections due to the unique anti-biofilm and anti-virulence activities.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxacilina / Infecciones Estafilocócicas / Staphylococcus aureus / Pruebas de Sensibilidad Microbiana / Biopelículas / Farmacorresistencia Bacteriana Múltiple / Factores de Virulencia / Antibacterianos Límite: Animals / Humans Idioma: En Revista: BMC Microbiol Asunto de la revista: MICROBIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxacilina / Infecciones Estafilocócicas / Staphylococcus aureus / Pruebas de Sensibilidad Microbiana / Biopelículas / Farmacorresistencia Bacteriana Múltiple / Factores de Virulencia / Antibacterianos Límite: Animals / Humans Idioma: En Revista: BMC Microbiol Asunto de la revista: MICROBIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Reino Unido